New Prospective Phosphodiesterase Inhibitors: Phosphorylated Oxazole Derivatives in Treatment of Hypertension

Purpose: One of the promising chemical groups for the development of new antihypertensive medicines, the action of which is associated with the inhibition of phosphodiesterase III (PDE3) activity, are phosphorylated oxazole derivatives (OVPs). This study aimed to prove experimentally the presence of...

Descripció completa

Dades bibliogràfiques

Autors principals:	Iryna V. Nizhenkovska, Kateryna V. Matskevych, Oksana I. Golovchenko, Oleksandr V. Golovchenko, Antonina D. Kustovska, Mikhaeel Van
Format:	Artigo
Idioma:	Inglês
Publicat:	Tabriz University of Medical Sciences 2023-03-01
Col·lecció:	Advanced Pharmaceutical Bulletin
Matèries:	hypertension molecular docking phosphodiesterase phosphodiesterase iii inhibitors phosphorilated oxazole derivatives
Accés en línia:	https://apb.tbzmed.ac.ir/PDF/apb-13-399.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!